LXS-196
-![LXS-196 Chemical Formula: C22H23F3N8O Solid Powder](http://labshops.com/cdn/shop/products/C-1368_173x173.jpg?v=1559938713)
Technical Data
Description
LXS-196 is an orally available protein kinase C (PKC) inhibitor with potential immunosuppressive and antineoplastic activities. Upon oral administration, protein kinase C inhibitor LXS-196 binds to and inhibits PKC, which prevents the activation of PKC-mediated signaling pathways. This may lead to the induction of cell cycle arrest and apoptosis in susceptible tumor cells. PKC, a serine/threonine protein kinase overexpressed in certain types of cancer cells, is involved in tumor cell differentiation, proliferation, invasion and survival.